NCT01713946 · Interventional trial
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Overall registry status Completed
Phase 3
Conditions Tuberous Sclerosis Complex-associated Refractory Seizures
Delaware Valley sites
- Children's Hospital of Philadelphia SC · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory